{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:18:52Z","timestamp":1788556732346,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R34DA046950"],"award-info":[{"award-number":["R34DA046950"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Community Ment Health J"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Most people with co-occurring opioid use disorder (OUD) and mental illness do not receive effective medications for treating OUD. To investigate perspectives of adults in a publicly-funded mental health system regarding medications for OUD (MOUD), we conducted semi-structured telephone interviews with 13 adults with OUD (current or previous diagnosis) receiving mental health treatment. Themes that emerged included: perceiving or using MOUDs as a substitute for opioids or a temporary solution to prevent withdrawal symptoms; negative perceptions about methadone\/methadone clinics; and viewing MOUD use as \u201ccheating\u201d. Readiness to quit was important for patients to consider MOUDs. All participants were receptive to discussing MOUDs with their mental health providers and welcomed the convenience of receiving care for their mental health and OUD at the same location. In conclusion, clients at publicly-funded mental health clinics support MOUD treatment, signaling a need to expand access and build awareness of MOUDs in these settings.<\/jats:p>","DOI":"10.1007\/s10597-022-01012-x","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T12:49:18Z","timestamp":1659098958000},"page":"345-356","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness"],"prefix":"10.1007","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7426-6387","authenticated-orcid":false,"given":"Derjung M.","family":"Tarn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison J.","family":"Ober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah B.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alanna","family":"Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"McCreary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Leamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Sheehe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Bromley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,29]]},"reference":[{"issue":"12","key":"1012_CR2","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1017\/S0033291719002307","volume":"50","author":"L Ashrafioun","year":"2020","unstructured":"Ashrafioun, L., Zerbo, K. R. A., Bishop, T. M., & Britton, P. C. (2020). Opioid use disorders, psychiatric comorbidities, and risk for suicide attempts among veterans seeking pain care. Psychological Medicine, 50(12), 2107\u20132112. https:\/\/doi.org\/10.1017\/S0033291719002307","journal-title":"Psychological Medicine"},{"issue":"Suppl 8","key":"1012_CR3","first-page":"S235","volume":"17","author":"O Baser","year":"2011","unstructured":"Baser, O., Chalk, M., Fiellin, D. A., & Gastfriend, D. R. (2011). Cost and utilization outcomes of opioid-dependence treatments. The American Journal of Managed Care, 17(Suppl 8), S235\u2013S248.","journal-title":"The American Journal of Managed Care"},{"key":"1012_CR4","volume-title":"The health belief model and personal health behavior","author":"MH Becker","year":"1974","unstructured":"Becker, M. H. (1974). The health belief model and personal health behavior. Slack."},{"issue":"2","key":"1012_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77\u2013101. https:\/\/doi.org\/10.1191\/1478088706qp063oa","journal-title":"Qualitative Research in Psychology"},{"key":"1012_CR6","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/978-981-10-5251-4_103","volume-title":"Handbook of research methods in health social sciences","author":"V Braun","year":"2019","unstructured":"Braun, V., Clarke, V., Hayfield, N., & Terry, G. (2019). Thematic analysis. In P. Liamputtong (Ed.), Handbook of research methods in health social sciences (pp. 843\u2013860). Springer."},{"key":"1012_CR7","doi-asserted-by":"publisher","first-page":"108007","DOI":"10.1016\/j.jsat.2020.108007","volume":"114","author":"E Bromley","year":"2020","unstructured":"Bromley, E., Tarn, D. M., McCreary, M., Hurley, B., Ober, A. J., & Watkins, K. E. (2020). Attitudes about medications for alcohol use disorder among individuals with serious mental illness: A health belief model analysis. Journal of Substance Abuse Treatment, 114, 108007. https:\/\/doi.org\/10.1016\/j.jsat.2020.108007","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"1012_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.2044-8260.1996.tb01193.x","volume":"35","author":"RJ Budd","year":"1996","unstructured":"Budd, R. J., Hughes, I. C. T., & Smith, J. A. (1996). Health beliefs and compliance with antipsychotic medication. British Journal of Clinical Psychology, 35(3), 393\u2013397. https:\/\/doi.org\/10.1111\/j.2044-8260.1996.tb01193.x","journal-title":"British Journal of Clinical Psychology"},{"issue":"1","key":"1012_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.socscimed.2011.10.009","volume":"74","author":"R Bussing","year":"2012","unstructured":"Bussing, R., Koro-Ljungberg, M., Noguchi, K., Mason, D., Mayerson, G., & Garvan, C. W. (2012). Willingness to use ADHD treatments: a mixed methods study of perceptions by adolescents, parents, health professionals and teachers. Social Science & Medicine, 74(1), 92\u2013100. https:\/\/doi.org\/10.1016\/j.socscimed.2011.10.009","journal-title":"Social Science & Medicine"},{"issue":"2","key":"1012_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/s0920-9964(99)00079-1","volume":"41","author":"IG Cabeza","year":"2000","unstructured":"Cabeza, I. G., Amador, M. S., L\u00f3pez, C. A., & Gonz\u00e1lez de Ch\u00e1vez, M. (2000). Subjective response to antipsychotics in schizophrenic patients: Clinical implications and related factors. Schizophrenia Research, 41(2), 349\u2013355. https:\/\/doi.org\/10.1016\/s0920-9964(99)00079-1","journal-title":"Schizophrenia Research"},{"key":"1012_CR11","unstructured":"California Department of Public Health Substance and Addiction Prevention Branch. CDPH Center for Health Statistics and Informatics Vital Statistics\u2014Multiple cause of death and California comprehensive death files. Retrieved July 28, 2022, from https:\/\/skylab.cdph.ca.gov\/ODdash\/"},{"key":"1012_CR12","doi-asserted-by":"publisher","first-page":"108146","DOI":"10.1016\/j.jsat.2020.108146","volume":"119","author":"K Cioe","year":"2020","unstructured":"Cioe, K., Biondi, B. E., Easly, R., Simard, A., Zheng, X., & Springer, S. A. (2020). A systematic review of patients\u2019 and providers\u2019 perspectives of medications for treatment of opioid use disorder. Journal of Substance Abuse Treatment, 119, 108146. https:\/\/doi.org\/10.1016\/j.jsat.2020.108146","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"1012_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pnpbp.2005.10.007","volume":"30","author":"G Gerra","year":"2006","unstructured":"Gerra, G., Leonardi, C., D\u2019Amore, A., Strepparola, G., Fagetti, R., Assi, C., Zaimovic, A., & Lucchini, A. (2006). Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30(2), 265\u2013272. https:\/\/doi.org\/10.1016\/j.pnpbp.2005.10.007","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"1012_CR14","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-2439","author":"CM Harbaugh","year":"2018","unstructured":"Harbaugh, C. M., Lee, J. S., Hu, H. M., McCabe, S. E., Voepel-Lewis, T., Englesbe, M. J., Brumett, C. M., & Waljee, C. F. (2018). Persistent opioid use among pediatric patients after surgery. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2017-2439","journal-title":"Pediatrics"},{"issue":"8","key":"1012_CR15","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1176\/appi.ps.56.8.954","volume":"56","author":"KM Harris","year":"2005","unstructured":"Harris, K. M., & Edlund, M. J. (2005). Use of mental health care and substance abuse treatment among adults with co-occurring disorders. Psychiatric Services, 56(8), 954\u2013959. https:\/\/doi.org\/10.1176\/appi.ps.56.8.954","journal-title":"Psychiatric Services"},{"issue":"5","key":"1012_CR16","doi-asserted-by":"publisher","first-page":"e204561","DOI":"10.1001\/jamanetworkopen.2020.4561","volume":"3","author":"KF Hawk","year":"2020","unstructured":"Hawk, K. F., D\u2019Onofrio, G., Chawarski, M. C., O\u2019Connor, P. G., Cowan, E., Lyons, M. S., Richardson, L., Rothman, R. E., Whiteside, L. K., Owens, P. H., Martel, S. H., Coupet, E., Jr, Pantalon, M., Curry, L., Fiellin, D. A., & Edelman, E. J. (2020). Barriers and facilitators to clinician readiness to provide Emergency Department-initiated buprenorphine. JAMA Network Open, 3(5), e204561. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.4561","journal-title":"JAMA Network Open"},{"issue":"3","key":"1012_CR17","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/PHH.0000000000000849","volume":"25","author":"K Hedberg","year":"2019","unstructured":"Hedberg, K., Bui, L. T., Livingston, C., Shields, L. M., & Van Otterloo, J. (2019). Integrating public health and health care strategies to address the opioid epidemic: The Oregon Health Authority\u2019s Opioid Initiative. Journal of Public Health Management and Practice, 25(3), 214\u2013220. https:\/\/doi.org\/10.1097\/PHH.0000000000000849","journal-title":"Journal of Public Health Management and Practice"},{"key":"1012_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/9781119973249.ch15","volume-title":"Qualitative research methods in mental health and psychotherapy","author":"H Joffe","year":"2011","unstructured":"Joffe, H. (2011). Thematic analysis. In D. Harper & A. R. Thompson (Eds.), Qualitative research methods in mental health and psychotherapy (pp. 209\u2013223). Wiley."},{"issue":"1\u20132","key":"1012_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.drugalcdep.2013.01.007","volume":"132","author":"CM Jones","year":"2013","unstructured":"Jones, C. M. (2013). Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers\u2014United States, 2002\u20132004 and 2008\u20132010. Drug and Alcohol Dependence, 132(1\u20132), 95\u2013100. https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.01.007","journal-title":"Drug and Alcohol Dependence"},{"issue":"16","key":"1012_CR20","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1001\/jama.2017.14567","volume":"318","author":"A Kolodny","year":"2017","unstructured":"Kolodny, A., & Frieden, T. R. (2017). Ten steps the federal government should take now to reverse the opioid addiction epidemic. JAMA, 318(16), 1537\u20131538. https:\/\/doi.org\/10.1001\/jama.2017.14567","journal-title":"JAMA"},{"key":"1012_CR21","doi-asserted-by":"publisher","first-page":"108714","DOI":"10.1016\/j.drugalcdep.2021.108714","volume":"223","author":"A Manhapra","year":"2021","unstructured":"Manhapra, A., Stefanovics, E., & Rosenheck, R. (2021). The association of opioid use disorder and homelessness nationally in the veterans health administration. Drug and Alcohol Dependence, 223, 108714. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108714","journal-title":"Drug and Alcohol Dependence"},{"key":"1012_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jsat.2018.12.003","volume":"99","author":"KE Moore","year":"2019","unstructured":"Moore, K. E., Roberts, W., Reid, H. H., Smith, K. M. Z., Oberleitner, L. M. S., & McKee, S. A. (2019). Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review. Journal of Substance Abuse Treatment, 99, 32\u201343. https:\/\/doi.org\/10.1016\/j.jsat.2018.12.003","journal-title":"Journal of Substance Abuse Treatment"},{"key":"1012_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jsat.2017.07.001","volume":"85","author":"JR Morgan","year":"2018","unstructured":"Morgan, J. R., Schackman, B. R., Leff, J. A., Linas, B. P., & Walley, A. Y. (2018). Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population. Journal of Substance Abuse Treatment, 85, 90\u201396. https:\/\/doi.org\/10.1016\/j.jsat.2017.07.001","journal-title":"Journal of Substance Abuse Treatment"},{"key":"1012_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1176\/appi.ps.202000818","volume":"73","author":"AJ Ober","year":"2021","unstructured":"Ober, A. J., Hunter, S. B., McCullough, C. M., Leamon, I., McCreary, M., Beas, I., Montero, A., Tarn, D. M., Bromley, E., Hurley, B., Sheehe, J., Martinez, J., & Watkins, K. E. (2021). Opioid use disorder among clients of community mental health clinics: Prevalence, characteristics, and treatment willingness. Psychiatric Services, 73, 271. https:\/\/doi.org\/10.1176\/appi.ps.202000818","journal-title":"Psychiatric Services"},{"issue":"5","key":"1012_CR25","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s11920-011-0222-2","volume":"13","author":"EM Oliva","year":"2011","unstructured":"Oliva, E. M., Maisel, N. C., Gordon, A. J., & Harris, A. H. S. (2011). Barriers to use of pharmacotherapy for addiction disorders and how to overcome them. Current Psychiatry Reports, 13(5), 374. https:\/\/doi.org\/10.1007\/s11920-011-0222-2","journal-title":"Current Psychiatry Reports"},{"key":"1012_CR26","doi-asserted-by":"publisher","first-page":"117822181775267","DOI":"10.1177\/1178221817752678","volume":"12","author":"H Pettersen","year":"2018","unstructured":"Pettersen, H., Landheim, A., Skeie, I., Biong, S., Brodahl, M., Benson, V., & Davidson, L. (2018). why do those with long-term substance use disorders stop abusing substances? A qualitative study. Substance Abuse, 12, 1178221817752678. https:\/\/doi.org\/10.1177\/1178221817752678","journal-title":"Substance Abuse"},{"issue":"4","key":"1012_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000584","volume":"14","author":"O Randall-Kosich","year":"2020","unstructured":"Randall-Kosich, O., Andraka-Christou, B., Totaram, R., Alamo, J., & Nadig, M. (2020). Comparing reasons for starting and stopping methadone, buprenorphine, and naltrexone treatment among a sample of white individuals with opioid use disorder. Journal of Addiction Medicine, 14(4), e44. https:\/\/doi.org\/10.1097\/ADM.0000000000000584","journal-title":"Journal of Addiction Medicine"},{"key":"1012_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2021.1962577","author":"BE Reid","year":"2021","unstructured":"Reid, B. E., & Palamar, J. J. (2021). Unmet need in relation to mental healthcare and past-month drug use among people with mental illness in the United States. Journal of Psychoactive Drugs. https:\/\/doi.org\/10.1080\/02791072.2021.1962577","journal-title":"Journal of Psychoactive Drugs"},{"issue":"6","key":"1012_CR29","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s11606-011-1962-8","volume":"27","author":"BR Schackman","year":"2012","unstructured":"Schackman, B. R., Leff, J. A., Polsky, D., Moore, B. A., & Fiellin, D. A. (2012). Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care. Journal of General Internal Medicine, 27(6), 669\u2013676. https:\/\/doi.org\/10.1007\/s11606-011-1962-8","journal-title":"Journal of General Internal Medicine"},{"key":"1012_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.drugpo.2019.09.003","volume":"74","author":"SM Silverstein","year":"2019","unstructured":"Silverstein, S. M., Daniulaityte, R., Martins, S. S., Miller, S. C., & Carlson, R. G. (2019). \u201cEverything is not right anymore\u201d: Buprenorphine experiences in an era of illicit fentanyl. International Journal of Drug Policy, 74, 76\u201383. https:\/\/doi.org\/10.1016\/j.drugpo.2019.09.003","journal-title":"International Journal of Drug Policy"},{"issue":"11","key":"1012_CR31","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1037\/ccp0000600","volume":"88","author":"TL Simpson","year":"2020","unstructured":"Simpson, T. L., Hawrilenko, M., Goldberg, S., Browne, K., Lehavot, K., & Borowitz, M. (2020). Treatment receipt patterns among individuals with co-occurring posttraumatic stress disorder (PTSD) and substance use disorders. Journal of Consulting and Clinical Psychology, 88(11), 1039\u20131051. https:\/\/doi.org\/10.1037\/ccp0000600","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"1012_CR32","volume-title":"The health belief model","author":"VJ Strecher","year":"1997","unstructured":"Strecher, V. J., & Rosenstock, I. M. (1997). The health belief model. Cambridge University Press."},{"key":"1012_CR1","unstructured":"Substance Abuse and Mental Health Services Administration. (2019). Key substance use and mental health indicators in the United States: Results from the 2019 National survey on drug use and health (Vol. 114). Retrieved July 28, 2022 from https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt29393\/2019NSDUHFFRPDFWHTML\/2019NSDUHFFR1PDFW090120.pdf"},{"issue":"2","key":"1012_CR33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1046\/j.1440-0979.2003.00277.x","volume":"12","author":"B Svedberg","year":"2003","unstructured":"Svedberg, B., Backenroth-Ohsako, G., & L\u00fctz\u00e9n, K. (2003). On the path to recovery: Patients\u2019 experiences of treatment with long-acting injections of antipsychotic medication. International Journal of Mental Health Nursing, 12(2), 110\u2013118. https:\/\/doi.org\/10.1046\/j.1440-0979.2003.00277.x","journal-title":"International Journal of Mental Health Nursing"},{"key":"1012_CR34","unstructured":"U.S. Department of Health and Human Services. (2019). Needs assessment methodologies in determining treatment capacity for substance use disorders: Final report. September 2019. Retrieved September 8, 2021, from https:\/\/aspe.hhs.gov\/sites\/default\/files\/migrated_legacy_files\/\/191836\/SUDNetCap.pdf"},{"issue":"8","key":"1012_CR35","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1176\/appi.ps.52.8.1062","volume":"52","author":"KE Watkins","year":"2001","unstructured":"Watkins, K. E., Burnam, A., Kung, F. Y., & Paddock, S. (2001). A national survey of care for persons with co-occurring mental and substance use disorders. Psychiatric Services, 52(8), 1062\u20131068. https:\/\/doi.org\/10.1176\/appi.ps.52.8.1062","journal-title":"Psychiatric Services"},{"key":"1012_CR36","volume-title":"How to integrate pharmacotherapy for substance use disorders at your mental health clinic","author":"KE Watkins","year":"2021","unstructured":"Watkins, K. E., Ober, A. J., Hunter, S. B., Hurley, B., Sheehe, J., Martinez, J., Bromley, E., Tarn, D. M., Beas, I., Montero, A., McCreary, M., Bloom, E. L., Cohen, C. C., Gardner, M., & Leamon, I. (2021). How to integrate pharmacotherapy for substance use disorders at your mental health clinic. RAND Corporation."},{"key":"1012_CR37","doi-asserted-by":"publisher","first-page":"107672","DOI":"10.1016\/j.drugalcdep.2019.107672","volume":"205","author":"SA Weicker","year":"2019","unstructured":"Weicker, S. A., Hayashi, K., Grant, C., Milloy, M. J., Wood, E., & Kerr, T. (2019). Willingness to take buprenorphine\/naloxone among people who use opioids in Vancouver, Canada. Drug and Alcohol Dependence, 205, 107672. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107672","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"1012_CR38","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/dar.12881","volume":"38","author":"RJ Winter","year":"2019","unstructured":"Winter, R. J., Stoov\u00e9, M., Agius, P. A., Hellard, M. E., & Kinner, S. A. (2019). Injecting drug use is an independent risk factor for reincarceration after release from prison: A prospective cohort study. Drug and Alcohol Review, 38(3), 254\u2013263. https:\/\/doi.org\/10.1111\/dar.12881","journal-title":"Drug and Alcohol Review"},{"key":"1012_CR39","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.12.031","volume":"160","author":"BJH Yarborough","year":"2016","unstructured":"Yarborough, B. J. H., Stumbo, S. P., McCarty, D., Mertens, J., Weisner, C., & Green, C. A. (2016). Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis. Drug and Alcohol Dependence, 160, 112\u2013118. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.12.031","journal-title":"Drug and Alcohol Dependence"}],"container-title":["Community Mental Health Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10597-022-01012-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10597-022-01012-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10597-022-01012-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T21:50:42Z","timestamp":1674251442000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10597-022-01012-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1012"],"URL":"https:\/\/doi.org\/10.1007\/s10597-022-01012-x","relation":{},"ISSN":["0010-3853","1573-2789"],"issn-type":[{"value":"0010-3853","type":"print"},{"value":"1573-2789","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,29]]},"assertion":[{"value":"13 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Tarn has been funded by Bristol Myers Squibb and Pfizer for unrelated investigator-initiated research grants. The other authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by RAND\u2019s institutional review board (IRB) and the Los Angeles County Department of Mental Health Human Subjects Research Committee, and included a waiver for signed informed consent. Verbal informed consent was obtained prior to the interview. All methods were carried out in accordance with relevant guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}